for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Agilent Technologies Inc

A.N

Latest Trade

146.92USD

Change

3.33(+2.32%)

Volume

700,596

Today's Range

143.49

 - 

147.67

52 Week Range

84.84

 - 

147.67

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
143.59
Open
143.49
Volume
700,596
3M AVG Volume
30.88
Today's High
147.67
Today's Low
143.49
52 Week High
147.67
52 Week Low
84.84
Shares Out (MIL)
304.70
Market Cap (MIL)
43,571.41
Forward P/E
34.96
Dividend (Yield %)
0.54

Next Event

Dividend For A.N - 0.1940 USD

Latest Developments

More

Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results

Agilent Technologies Announces Pricing Of $850 Mln Of Senior Notes

Agilent Technologies Announces Proposed Offering Of Senior Notes

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.

Industry

Scientific & Technical Instr.

Contact Info

5301 Stevens Creek Blvd

SANTA CLARA, CA

95051-7201

United States

+1.408.3458886

https://www.agilent.com/

Executive Leadership

Boon Hwee Koh

Non-Executive Independent Chairman of the Board

Michael R. McMullen

President, Chief Executive Officer, Director

Robert W. McMahon

Chief Financial Officer, Senior Vice President

Michael Tang

Senior Vice President, General Counsel, Secretary

Dominique P. Grau

Senior Vice President of Human Resources and Global Communications

Key Stats

1.95 mean rating - 20 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

4.9K

2019

5.2K

2020

5.3K

2021(E)

6.2K
EPS (USD)

2018

2.790

2019

3.110

2020

3.280

2021(E)

4.137
Price To Earnings (TTM)
48.10
Price To Sales (TTM)
7.49
Price To Book (MRQ)
9.05
Price To Cash Flow (TTM)
35.40
Total Debt To Equity (MRQ)
60.96
LT Debt To Equity (MRQ)
56.69
Return on Investment (TTM)
11.46
Return on Equity (TTM)
9.32

Latest News

Latest News

BRIEF-Agilent Technologies Announces Pricing Of $500 Million Of Senior Notes

* AGILENT TECHNOLOGIES ANNOUNCES PRICING OF $500 MILLION OF SENIOR NOTES Source text for Eikon: Further company coverage:

BRIEF-Agilent Technologies Files For Potential Senior Notes Offering Size Not Disclosed

* AGILENT TECHNOLOGIES INC FILES FOR POTENTIAL SENIOR NOTES OFFERING; SIZE NOT DISCLOSED - SEC FILING Source: (https://bit.ly/2U147ih) Further company coverage:

BRIEF-Agilent Technologies Q2 GAAP Earnings Per Share $0.32

* AGILENT REPORTS SECOND-QUARTER FISCAL YEAR 2020 FINANCIAL RESULTS

BRIEF-Agilent PD-L1 Assay Receives FDA Approval For Use As Companion Diagnostic

* AGILENT PD-L1 ASSAY RECEIVES FDA APPROVAL FOR USE AS A COMPANION DIAGNOSTIC

BRIEF-Agilent Gets FDA Approval For Pd-L1 Companion Diagnostic On Dako Omnis

* AGILENT RECEIVES FDA APPROVAL FOR PD-L1 COMPANION DIAGNOSTIC ON DAKO OMNIS

BRIEF-Agilent Technologies Enters Into Amendment No. 3 To Credit Agreement

* AGILENT TECHNOLOGIES INC - ON APRIL 17CO ENTERED INTO AMENDMENT NO. 3 TO CREDIT AGREEMENT DATED AS OF MARCH 13, 2019

BRIEF-Agilent withdraws Q2, FY guidance, cites coronavirus impact

* AGILENT -- WITHDRAWING ITS SECOND-QUARTER AND FISCAL YEAR 2020 GUIDANCE PROVIDED ON FEB. 18

BRIEF-Agilent Technologies To Adjourn Annual Meeting Until April 17, 2020

* AGILENT TECHNOLOGIES TO ADJOURN ANNUAL MEETING UNTIL APRIL 17, 2020

BRIEF-Agilent Technologies Reports Q1 Non-GAAP Earnings Per Share $0.81

* AGILENT TECHNOLOGIES REPORTS FIRST QUARTER FISCAL YEAR 2020 FINANCIAL RESULTS

BRIEF-Pershing Square Capital Management Lp Raises Sole Share Stake In Agilent Technologies

* PERSHING SQUARE CAPITAL MANAGEMENT LP RAISES SOLE SHARE STAKE IN AGILENT TECHNOLOGIES INC BY 11.4 PERCENT TO 3.25 MILLION SHARES - SEC FILING

BRIEF-Agilent Technologies Announces Twist Bioscience Agrees To Pay $22.5 Million Settlement In Ip Litigation

* AGILENT TECHNOLOGIES ANNOUNCES TWIST BIOSCIENCE AGREES TO PAY $22.5 MILLION SETTLEMENT IN IP LITIGATION

BRIEF-Twist Bioscience Announces Settlement Deal With Agilent

* TWIST BIOSCIENCE ANNOUNCES SETTLEMENT AGREEMENT WITH AGILENT

Ackman's Pershing Square exits Starbucks, sticks by Chipotle, sees gains at Agilent

Investor William Ackman told clients on Wednesday that Pershing Square Capital Management exited its Starbucks Corp <SBUX.O> position as future growth looks less robust but will stick with last year's biggest winner, Chipotle Mexican Grill Inc. <CMG.N>.

Ackman's Pershing Square exits Starbucks, sticks by Chipotle, sees gains at Agilent

Investor William Ackman updated clients on his portfolio on Wednesday saying his Pershing Square Capital Management exited its Starbucks Corp. position as future growth looks less robust but will stick with last year's biggest winner, Chipotle Mexican Grill Inc..

Ackman's Pershing Square makes new bet on Agilent Technologies

Billionaire investor William Ackman's hedge fund Pershing Square Capital Management said Monday it bought shares in testing equipment company Agilent Technologies Inc, only its second new investment this year as the fund has reported a 51% return.

Ackman's Pershing Square makes new bet on Agilent Technologies

Billionaire investor William Ackman's hedge fund Pershing Square Capital Management has made a new bet on Agilent Technologies Inc, according to a regulatory filing made on Monday.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up